Product NDC: | 67457-183 |
Proprietary Name: | Etomidate |
Non Proprietary Name: | etomidate |
Active Ingredient(s): | 2 mg/mL & nbsp; etomidate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 67457-183 |
Labeler Name: | Mylan Institutional LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091297 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130426 |
Package NDC: | 67457-183-20 |
Package Description: | 10 VIAL, SINGLE-USE in 1 CARTON (67457-183-20) > 20 mL in 1 VIAL, SINGLE-USE (67457-183-99) |
NDC Code | 67457-183-20 |
Proprietary Name | Etomidate |
Package Description | 10 VIAL, SINGLE-USE in 1 CARTON (67457-183-20) > 20 mL in 1 VIAL, SINGLE-USE (67457-183-99) |
Product NDC | 67457-183 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | etomidate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20130426 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Institutional LLC |
Substance Name | ETOMIDATE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | General Anesthesia [PE],General Anesthetic [EPC] |